Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Swollen Knee Treatment Market: By Type (Medications- Corticosteroids, Patient-controlled analgesia pumps, Surgery- Arthrocentesis, Arthroscopy, Knee replacement, and Others), End-User (Hospitals, Clinics, and Others) -Forecast Till 2030


ID: MRFR/Pharma/4945-HCR | 100 Pages | Author: Rahul Gotadki| May 2024

Swollen Knee Treatment Market Scenario


The Swollen Knee Treatment market is projected to reach USD 1.92 Billion by 2030 at 4.40% CAGR during the forecast period 2022-2030.


Knee swelling or occasionally mentioned as “water on the knee” is a condition where excess fluid gets accumulated in an around the knee joint. This conditions in medical terms are referred to as “knee effusion”. The swollen knee can result due to injuries such as torn ligament, cartilage tear or broken bones. The increasing number of geriatric populations followed by the rising frequency of musculoskeletal diseases, a growing number of surgeries undertaken is projected to grow the swollen knee treatment market. The operating procedure of knee replacement is inclusive of various steps taken to implant the artificial device and replacement of the damaged knee.


The swollen knee treatment market is anticipated to grow due to several factors such as the growing rate of elderly aged diseases like obesity, arthritis, osteoporosis, diabetes and sports-related injuries. Contrary, due to existing and upcoming advance technologies such as minimally invasive surgery and improved implant supplies are making it more broadly accepted even by the younger population.


In spite of being a widely used technique for curing extremely debilitating diseases, such as rheumatoid arthritis, the swollen knee treatment market is confronting some challenges such as financial slowdown which is avoiding the growth of the market. Other growth restraining factors of the swollen knee treatment market are intense competition, huge surgical cost, growing awareness for some non-surgical treatment methods such as exercises, shoe inserts, walking aids, weight loss programs, and painkiller medicines.


Segmentation


The swollen knee treatment market has been segmented on the basis of type and end-users.


On the basis of type, the market has been classified as medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery. The medications have been segmented into opioids and corticosteroids and others. The surgery is segmented into arthrocentesis, arthroscopy and knee replacement. The knee replacement is further segmented into total knee replacement, unicompartmental knee replacement, and others.


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European swollen knee treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The swollen knee treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The swollen knee treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Swollen Knee Treatment Market Share, by Region, 2017 (%)


Swollen Knee Treatment Market


Source: MRFR Analysis


In the swollen knee treatment market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetes patients, increasing number of surgeries, and increasing demand for advanced treatment procedures are boosting the European market.


The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism.


The market in the Middle East and Africa is expected to account for the smallest share of the swollen knee treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the swollen knee treatment market are Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics, C.R.Bard ,Teleflex  ,Smiths Medical.


Swollen Knee Treatment Market, by Type



  • Medications

  • Corticosteroids

  • Opioids

  • Others

  • Patient-controlled analgesia (PCA) pumps

  • Nerve blocks

  • Liposomal bupivacaine

  • Surgery

  • Arthrocentesis

  • Arthroscopy

  • Knee replacement

  • Total knee replacement

  • Uni-compartmental knee replacement

  • Others


Swollen Knee Treatment Market, by End-User



  • Hospitals

  • Clinics

  • Ambulatory Surgery Centers

  • Others


Swollen Knee Treatment Market, by Region



  • Americas

    • North America

    • US

    • Canada

    • South America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Advanced Surgical Trainees

  • Governmental Agency

  • Educational Organizations

  • Medical Device Manufacturers

  • Research Institutes and Academic Centers

  • Market Research and Consulting

Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2022-2030: 4.40% CAGR
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Basis of type and End-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics, C.R.Bard ,Teleflex ,Smiths Medical.
  Key Market Opportunities ·  Rising frequency of musculoskeletal diseases ·  A growing number of surgeries
  Key Market Drivers ·  Growing rate of elderly aged diseases like obesity, arthritis, osteoporosis, diabetes ·  Sports-related injuries


Frequently Asked Questions (FAQ) :

Swollen knee treatment market would be restrained by huge surgical cost, awareness of non-surgical treatment methods, such as exercises, weight loss programs, walking aids, shoe inserts, and painkiller medicines.

Swollen knee treatment market patient-controlled analgesia (PCA) pumps, medications, liposomal bupivacaine, nerve blocks, and surgery.

Swollen knee treatment market would include clinics, ambulatory surgery centers, hospitals, and others.

The companies are Zimmer Holdings, Stryker Corporation, DePuy Companies Inc., Smith & Nephew Plc., Biomet Inc., Wright Medical Group Inc., B. Braun Melsungen AG, Exactech, Merck & Co., Pfizer Pharmaceuticals Inc., AngioDynamics, C.R.Bard , Fresenius Kabi, Teleflex, and Smiths Medical.

North America is the largest swollen knee treatment market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.